Long-lasting fundraising support for BiPER Therapeutics

15 May 2026 | by Andrii Koniukh

Biper case main

BACK TO BLOG

We began supporting BiPER Therapeutics at the very start of their fundraising journey, at the preclinical stage. Since then, we have continuously helped refine their materials and provided ongoing support for their investor communications.

Pitch Deck

Pitch Deck

Video

Video

Website

Website

Pitch deck adaptation, 2022

The pitch deck was enriched with visuals, upgraded, and restructured to clearly present complex scientific and clinical data as a concise, investor-ready narrative.

The redesigned deck supports fundraising and partner discussions by translating detailed research results into a clear and compelling visual story.

Biper new slides

"The newly developed comms assets contributed to BiPER Therapeutics fundraising rounds and enables BiPER Tx making the difference in world-classs high level awards Boston Biotech Summit Galien Fondation Price and World Health expo Start-up pitch competition.

I decided to try working with Nanobot and was not disappointed. I was impressed by their systematic approach and the results I received, and I look forward to continuing our collaboration with this company.

Thank you for your patience and the great job."

Mehdi Chelbi

Mehdi Chelbi

CEO & Co-Founder BIPER Therapeutics

 

 

Sign up for our newsletter